ОГЛЯД ДИСКУСІЙ ТА ПРИЙНЯТТЯ РІШЕНЬ ЩОДО ТОТАЛЬНОЇ НЕОАД’ЮВАНТНОЇ ТЕРАПІЇ при ДИСТАЛЬНОму РАКУ ПРЯМОЇ КИШКИ

• Datum: 2023
• Hauptverfasser: Gordiichuk, P., Gordiichuk, M.
• Format: Artikel
• Sprache: English
• Veröffentlicht: PH Akademperiodyka 2023
• Schlagworte: дистальний рак прямої кишки; тотальна неоад’ювантна терапія; комплексне лікування; етапи лікування; медикаментозне лікування; променева терапія.
• Online Zugang: https://exp-oncology.com.ua/index.php/Exp/article/view/2022-3-2
• Назва журналу: Experimental Oncology

Advances implemented in the complex treatment of distal rectal cancer led to a decrease in the number of loco-regional recurrences to 5–10%, but high rates of distant metastases remain at up to 30%. They lead to disappointing long-term oncological results, which requires the search for improvement of each of the stages of complex treatment. As a consequence of the questionable effectiveness of adjuvant polychemotherapy for distal rectal cancer, the question of the possibility of transferring drug treatment from an adjuvant to a neoadjuvant regimen is reasonably raised. The presented options for full neoadjuvant therapy have been developed and tested in leading oncology centers and are based on National Comprehensive Cancer Network Version 1.2022 recommendations. It is premature to make categorical conclusions regarding the recommendation of one or another variant of their implementation. Our preliminary clinical results confirmed the need for an additional stage of restaging in the second option, after 16 weeks of polychemotherapy before chemoradiation, in order to exclude the generalization of the disease. Therefore, there is a need for a prospective, controlled intercentre study to answer some unresolved questions.